<DOC>
	<DOCNO>NCT02058537</DOCNO>
	<brief_summary>The primary goal study ease symptom patient Eosinophilic Esophagitis ( EoE ) test effectiveness drug bethanechol relieve symptom .</brief_summary>
	<brief_title>Bethanechol Eosinophilic Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Bethanechol</mesh_term>
	<criteria>Male Female Age 1875 Symptoms associate EoE dysphagia , heartburn , vomit , abdominal pain , food impaction Subject sign informed consent administration bethanechol informs patient potential adverse event Clinically pathologically proven EoE Known allergy bethanechol Asthma Pregnant breastfeed woman Severe neurological problem Severe diabetes Achalasia Known allergy lidocaine local anesthetic Hypothyroidism Peptic ulcer Pronounced bradycardia hypotension Vasomotor instability Coronary artery disease Epilepsy Parkinsonism Weakened gastrointestinal bladder wall Mechanical obstruction gastrointestinal tract bladder neck Urinary bladder surgery 6 month prior study Gastrointestinal resection anastomosis Spastic gastrointestinal disturbance Acute inflammatory lesion gastrointestinal tract Peritonitis Marked vagotonia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>